Share：
Share this content in WeChat
X
[Chinese][PDF]124377
• Review •
Quantitative assessment of MRI for treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A review
WAN Lijuan  ZHANG Hongmei 

Cite this article as: Wan LJ, Zhang HM. Quantitative assessment of MRI for treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A review. Chin J Magn Reson Imaging, 2019, 10(8): 625-628. DOI:10.12015/issn.1674-8034.2019.08.014.


[Abstract] Neoadjuvant chemoradiotherapy (NCRT) followed by surgery has become the standard of care for patients with locally advanced rectal cancer. Accurate evaluation of response to nCRT is helpful for guiding personalized treatment. Nowadays, magnetic resonance imaging (MRI) is one of the main tools used to response evaluation. Quantitative response evaluation based on normal MRI, functional MRI and radiomics can provide information beyond morphology, it is expected to improve the accuracy. In the review, we discuss the strengths and weakness of quantify MRI, including normal MRI, functional MRI and radiomics, for response evaluation after nCRT.
[Keywords] magnetic resonance imaging；rectal neoplasms；neoadjuvant chemoradiotherapy；quantitative response evaluation

WAN Lijuan Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

ZHANG Hongmei* Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

*Corresponding to: Zhang HM, E-mail: 13581968865@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Key Program Research Project No. 2016YFC0904600 Special Scientific Research Projects of Beijing Science and Technology Project No. Z161100000516101 Beijing Hope Marathon Special Fund No. LC2016A05
Received  2019-04-03
Accepted  2019-05-08
DOI: 10.12015/issn.1674-8034.2019.08.014
Cite this article as: Wan LJ, Zhang HM. Quantitative assessment of MRI for treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A review. Chin J Magn Reson Imaging, 2019, 10(8): 625-628. DOI:10.12015/issn.1674-8034.2019.08.014.

[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69(1): 7-34.
[2]
Valentini V, Coco C, Cellini N, et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiation Oncology Biol Phys, 1998, 40(5): 1067-1075.
[3]
Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol, 2010, 11(9): 835-844.
[4]
Jackson EF. Quantitative imaging: The translation from research tool to clinical practice. Radiology, 2018, 286(2): 499-501.
[5]
Press RH, Shu HG, Shim H, et al. The use of quantitative imaging in radiation oncology: A quantitative imaging network (QIN) perspective. Int J Radiation Oncology Biol Phys, 2018, 102(4): 1219-1235.
[6]
Stollfuss JC, Becker K, Sendler A, et al. Rectal carcinoma: High-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens. Radiology, 2006, 241(1): 132-141.
[7]
Kluza E, Rozeboom ED, Maas M, et al. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer. Eur Radiol, 2013, 23(1): 253-261.
[8]
Martens MH, van Heeswijk MM, van den Broek JJ, et al. Prospective, multicenter validation study of magnetic resonance volumetry for response assessment after preoperative chemoradiation in rectal cancer: Can the results in the literature be reproduced?. Int J Radiation Oncology Biol Phys, 2015, 93(5): 1005-1014.
[9]
Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology, 2009, 250(3): 730-739.
[10]
Tarallo N, Angeretti MG, Bracchi E, et al. Magnetic resonance imaging in locally advanced rectal cancer: Quantitative evaluation of the complete response to neoadjuvant therapy. Polish J Radiol, 2018, 83: 600-609.
[11]
Kim S, Han K, Seo N, et al. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol, 2018, 28(12): 5231-5240.
[12]
Pham TT, Liney GP, Wong K, et al. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer. Br J Radiol, 2017, 90(1072): 20151078.
[13]
Lambregts DMJ, Boellaard TN, Beets-Tan RGH. Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: A pictorial review. Insights Into Imaging, 2019, 10(1): 15.
[14]
Intven M, Reerink O, Philippens ME,et al. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol, 2013, 189(2): 117-122.
[15]
Lambrecht M, Vandecaveye V, De Keyzer F, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiation Oncology Biol Phys, 2012, 82(2): 863-870.
[16]
Kim SH, Lee JY, Lee JM, et al. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol, 2011, 21(5): 987-995.
[17]
Genovesi D, Filippone A, Ausili Cefaro G, et al. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. Eur J Surg Oncol, 2013, 39(10): 1071-1078.
[18]
Blazic IM, Lilic GB, Gajic MM. Quantitative assessment of rectal cancer response to neoadjuvant combined chemotherapy and radiation therapy: Comparison of three methods of positioning region of interest for ADC measurements at diffusion-weighted MR imaging. Radiology, 2017, 282(2): 418-428.
[19]
Fusco R, Sansone M, Granata V, et al. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among standardized index of shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters. Abdominal Radiology, 2018. DOI: 10.1007/s00261-018-1801-z.
[20]
Dijkhoff RAP, Beets-Tan RGH, Lambregts DMJ, et al. Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. Eur J Radiol, 2017, 95(10): 155-168.
[21]
Oberholzer K, Menig M, Pohlmann A, et al. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI. J Magn Reson Imaging, 2013, 38(1): 119-126.
[22]
Kim MJ, Lee SJ, Lee JH, et al. Detection of rectal cancer and response to concurrent chemoradiotherapy by proton magnetic resonance spectroscopy. Magn Reson Imaging, 2012, 30(6): 848-853.
[23]
Atkin G, Taylor NJ, Daley FM, et al. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis. Br J Surgery, 2006, 93(8): 992-1000.
[24]
Enkhbaatar NE, Inoue S, Yamamuro H, et al. MR imaging with apparent diffusion coefficient histogram analysis: Evaluation of locally advanced rectal cancer after chemotherapy and radiation therapy. Radiology, 2018, 288(1): 129-137.
[25]
Palmisano A, Esposito A, Rancoita PMV, et al. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?. Clin Radiol,2018, 73(10): 911-917.
[26]
Horvat N, Veeraraghavan H, Khan M, et al. MR imaging of rectal cancer: Radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology, 2018, 287(3): 833-843.
[27]
Pham TT, Liney G, Wong K, et al. Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer. BMC Cancer, 2017, 17(1): 465.
[28]
Bulens P, Couwenberg A, Haustermans K, et al. Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer. Radiother Oncol, 2018, 126(3): 437-442.
[29]
Prezzi D, Goh V. Rectal cancer magnetic resonance imaging: Imaging beyond morphology. Clin Oncol, 2016, 28(2): 83-92.

PREV Research progress of functional magnetic resonance imaging techniques for evaluating the response to neoadjuvant chemotherapy in breast cancer
NEXT Applications of amide proton transfer weighted imaging in tumor
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn